3Read A, Ramwell H, Storer H, et al. A primary care intervention programme for obesity and coronary heart disease risk factor reduction. Br J Gen Pratt, 2004, 54 (501) : 272-278.
4Shimlzu M, Koizumi J, Miyamoto S, et M. Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia:the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial. Int J Cardiol, 2005, 99 (3) : 395-401.
5Brohet C, Banal S, Alings AM, et al. LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia. Curt Med Res Opin, 2005, 21 (4) :571-578.
6Lucas CP, Boldrin MN, Reaven GM. Effect of orlistat added to diet (30% of calories from fat) on plasma lipids, glucose, and insulin in obese patients with hypercholesterolemia. Am J Cardiol, 2003, 91 (8) : 961-964.
7Hutton B, Fergusson D. Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials. Am J Clin Nutr, 2004, 80(6) : 1461-1468.
8Kaya A, Aydin N, Topsever P, et al. Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients. Biomed Pharmaeother, 2004, 58 (10): 582-587.
10Collins R,Armitage J,Parish S,et al.MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet,The . 2003
